Impact of HBV infection on clinical outcomes in patients with metabolic dysfunction-associated fatty liver disease

BACKGROUND & AIMS: The new name and diagnostic criteria of metabolic-associated fatty liver disease (MAFLD) was proposed in 2020. Although chronic HBV infection has protective effects on lipid profiles and hepatic steatosis, the impact of chronic HBV infection on clinical outcomes of MAFLD requi...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Yu-Ming, Hsieh, Tsung-Han, Wang, Chia-Chi, Kao, Jia-Horng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432217/
https://www.ncbi.nlm.nih.gov/pubmed/37600956
http://dx.doi.org/10.1016/j.jhepr.2023.100836

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432217/
https://www.ncbi.nlm.nih.gov/pubmed/37600956
http://dx.doi.org/10.1016/j.jhepr.2023.100836

Ejemplares similares